Financhill
Sell
21

RVX.TO Quote, Financials, Valuation and Earnings

Last price:
$0.04
Seasonality move :
14.29%
Day range:
$0.04 - $0.04
52-week range:
$0.04 - $0.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1K
Avg. volume:
46.2K
1-year change:
-20%
Market cap:
$11.4M
Revenue:
--
EPS (TTM):
-$0.03

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Resverlogix has 12400% upside to fair value with a price target of -- per share.

RVX.TO vs. S&P 500

  • Over the past 5 trading days, Resverlogix has overperformed the S&P 500 by 14.46% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Resverlogix does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Resverlogix revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Resverlogix reported revenues of --.

Earnings Growth

  • Resverlogix earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Resverlogix reported earnings per share of $0.03.
Enterprise value:
36.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-7.34x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$11M -$7.7M -$6.4M -$1.5M -$1.6M
EBITDA -$5.3M -$10M -$14.7M $2.8M -$6.1M
Diluted EPS -$0.03 -$0.05 -$0.03 -- $0.03
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $1.5M $4.1M -- $1.8M $2.5M
Total Assets $13.4M $12.9M -- $10.1M $11M
Current Liabilities $14M $26.5M -- $39.5M $40.4M
Total Liabilities $62.9M $88.5M -- $109M $135M
Total Equity -$49.5M -$75.7M -- -$99M -$124M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$4M -$5M -$4.2M -$2.4M -$1.3M
Cash From Investing -$713.7K -$658K -$505.8K -$186K -$176.2K
Cash From Financing $4.1M $5.8M $4.9M $2.7M $1.6M
Free Cash Flow -$4.6M -$5.7M -$4.9M -$2.7M -$1.7M
RVX.TO
Sector
Market Cap
$11.4M
$32.8M
Price % of 52-Week High
42.11%
46.28%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-20%
-35.38%
Beta (5-Year)
0.659
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.04
200-day SMA
Sell
Level $0.05
Bollinger Bands (100)
Sell
Level 0.04 - 0.04
Chaikin Money Flow
Sell
Level -7.7M
20-day SMA
Sell
Level $0.04
Relative Strength Index (RSI14)
Sell
Level 46.06
ADX Line
Sell
Level 15.51
Williams %R
Neutral
Level -50
50-day SMA
Sell
Level $0.04
MACD (12, 26)
Sell
Level 0.00
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Neutral
Level 7.8M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Stock Forecast FAQ

In the current month, RVX.TO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RVX.TO average analyst price target in the past 3 months is --.

  • Where Will Resverlogix Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Resverlogix share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Resverlogix?

    Analysts are divided on their view about Resverlogix share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Resverlogix is a Sell and believe this share price will drop from its current level to --.

  • What Is Resverlogix's Price Target?

    The price target for Resverlogix over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is RVX.TO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Resverlogix is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of RVX.TO?

    You can purchase shares of Resverlogix via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Resverlogix shares.

  • What Is The Resverlogix Share Price Today?

    Resverlogix was last trading at $0.04 per share. This represents the most recent stock quote for Resverlogix. Yesterday, Resverlogix closed at $0.04 per share.

  • How To Buy Resverlogix Stock Online?

    In order to purchase Resverlogix stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Warren Buffett Buy Amazon Stock?
Why Did Warren Buffett Buy Amazon Stock?

When investors think of tech stocks in Warren Buffett’s portfolio,…

Where Will RocketLab Stock Be In 5 Years?
Where Will RocketLab Stock Be In 5 Years?

Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…

Is MO dividend Worth It?
Is MO dividend Worth It?

Altria Group (NYSE: MO) is paying investors $1.02 a share…

Stock Ideas

Buy
64
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
83
GMS alert for Jun 23

GMS [GMS] is up 0.03% over the past day.

Buy
54
SMLR alert for Jun 23

Semler Scientific [SMLR] is up 16.13% over the past day.

Buy
57
GXO alert for Jun 23

GXO Logistics [GXO] is up 2.42% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock